Last Updated: July 5, 2026

OMNIPAQUE Drug Patent Profile

Name: OMNIPAQUE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Omnipaque, and when can generic versions of Omnipaque launch?

Omnipaque is a drug marketed by Ge Healthcare and is included in two NDAs.

The generic ingredient in OMNIPAQUE is iohexol. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the iohexol profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Omnipaque

A generic version of OMNIPAQUE was approved as iohexol by AMNEAL on November 13^th, 2025.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for OMNIPAQUE?
What are the global sales for OMNIPAQUE?
What is Average Wholesale Price for OMNIPAQUE?

Summary for OMNIPAQUE

US Patents:	0
Applicants:	1
NDAs:	2
Drug Prices:	Drug price information for OMNIPAQUE
What excipients (inactive ingredients) are in OMNIPAQUE?	OMNIPAQUE excipients list
DailyMed Link:	OMNIPAQUE at DailyMed

Drug patent expirations by year for OMNIPAQUE

US Patents and Regulatory Information for OMNIPAQUE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ge Healthcare	OMNIPAQUE 12	iohexol	SOLUTION;ORAL	018956-009	Apr 17, 2018		RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ge Healthcare	OMNIPAQUE 300	iohexol	SOLUTION;INJECTION, ORAL, RECTAL	018956-003	Dec 26, 1985	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ge Healthcare	OMNIPAQUE 210	iohexol	INJECTABLE;INJECTION	018956-006	Jun 30, 1989		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.